Publications

Publications in peer-reviewed journals by research topic

For all publications, see my CV.

Demand, Pricing and Spending of Prescription Drugs

An Analysis of US Net Cancer Drug Launch Prices and Clinical Efficacy and Certainty of Evidence from 2008 to 2022

Sumaya Abuloha, Ben Harvey, Shu Niu, Alaa Alshehri, Melissa Miri, Katherine Clifford, James Chambers and Mikael Svensson

Health Affairs Scholar, 2025, 3: qxaf051.

Concentration of Spending and Share of Specialty Drug Spending in Medicare Part D over a 10-Year Period

Shu Niu, Laura E. Happe, Sumaya Abuloha and Mikael Svensson

Journal of Managed Care & Specialty Pharmacy, 2024, 30: 1355-1363.

Cancer drugs reimbursed with limited evidence on overall survival and quality of life: do follow-up studies confirm patient benefits?

Gabriella Chauca Strand, Naimi Johansson, Niklas Jakobsson, Carl Bonander and Mikael Svensson

Clinical Drug Investigation, 2023: 43: 621 - 633.

Assessment of the clinical and cost-effectiveness evidence in the reimbursement decisions of new cancer drugs

Gabriella Chauca Strand, Carl Bonander, Niklas Jakobsson, Naimi Johansson and Mikael Svensson

ESMO Open, 2022, 7: 100569.

Regional Variation in Prescription Drug Spending: Evidence from Regional Migrants in Sweden

Naimi Johansson and Mikael Svensson

Health Economics, 2022, 31: 1862-1877.

The Impact of Cost-Sharing on Prescription Drug Demand: Evidence from a Double-Difference Regression Kink Design

Simona Gamba, Niklas Jakobsson and Mikael Svensson

European Journal of Health Economics, 2022, 23: 1591-1599.

TLV:s betalningsvilja för nya läkemedel har analyserats (in Swedish)

Mikael Svensson and Fredrik Nilsson

Läkartidningen, 2016, 113: 1280 (1-4).

Reimbursement decisions for pharmaceuticals in Sweden: the impact of disease severity and cost-effectiveness

Mikael Svensson, Fredrik Nilsson and Karl Arnberg

Pharmacoeconomics, 2015, 33: 1229-1336.

Demand of Healthcare

Place or Patient as the Driver of regional variation in healthcare spending – discrepancies by category of care

Naimi Johansson, Niklas Jakobsson and Mikael Svensson

Social Science & Medicine, 2024, 342: 116571.

Reductions in out-of-pocket prices and forward-looking moral hazard in health care demand

Naimi Johansson, Sonja C de New, Johannes S Kunz, Dennis Petrie, and Mikael Svensson

Journal of Health Economics, 2023, 82: 102710.

Long-term effects on healthcare utilization among spouses of persons with stroke

Frida Labori, Carl Bonander, Mikael Svensson and Josefine Persson

BMC Health Services Research, 2023, 23: 1298.

Stated preferences for human papillomavirus vaccination for adolescents in selected communities in Ibadan, Southwest Nigeria: A discrete choice experiment

Folusho M. Balogun, Olayemi O. Omotade, and Mikael Svensson

Human Vaccines & Immunotherapeutics, 2022, 18: e2124091.

Effects of Primary Care Cost-Sharing among Young Adults: Varying Impact across Income Groups and Gender

Naimi Johansson, Niklas Jakobsson and Mikael Svensson

European Journal of Health Economics, 2019, 20: 1271-1280.

Regional variation in health care utilization in Sweden – the importance of demand-side factors

Naimi Johansson, Niklas Jakobsson and Mikael Svensson

BMC Health Services Research, 2018, 18: 403.

Copayments and Physician Visits: A panel data study of Swedish regions 2003-2012

Niklas Jakobsson and Mikael Svensson

Health Policy, 2016, 120: 1095-1099.

The effects of copayments on primary care utilization: Results from a Quasi-experiment

Niklas Jakobsson and Mikael Svensson

Applied Economics, 2016: 3752-3762.

Economic Evaluation Methods

Reproducibility of published model-based cancer drug cost-effectiveness analyses: a study protocol for a cross-sectional analysis

Mikael Svensson, Jonathan Siverskog, Naimi Johansson and Martin Henriksson

BMJ Open, 2025, 15:e096719.

Using Causal Forests to Asses Heterogeneity in Cost-Effectiveness Analysis

Carl Bonander and Mikael Svensson

Health Economics, 2021, 30: 1818-1832.

Willingness to pay for health improvements using stated preferences: prevention vs treatment

Ellen Wolff, Sofie Larsson, Mikael Svensson

Value in Health, 2020, 23: 1384-1390.

Valuation of Health Risks

Henrik Andersson, Arne Risa Hole and Mikael Svensson

Oxford Research Encyclopedia of Economics and Finance, 2019, Oxford University Press.

What should guide priority setting in health care? A study of public preferences in Sweden

Linda Ryen, Niklas Jakobsson and Mikael Svensson

Nordic Journal of Health Economics, 2019, 7: 82-89.

Mapping functions in health-related quality of life: mapping from the Achilles Tendon Rupture Score (ATRS) to the EQ-5D

Ay Yen Hua, Olof Westin, Eric Hamrin-Senorski, Jón Karlsson, Eleonor Svantesson, Kristian Samuelsson and Mikael Svensson

Knee Surgery, Sports Traumatology, Arthroscopy, 2018, 26: 3083-3088.

Estimating a constant WTP per QALY – a mission impossible?

Björn Sund and Mikael Svensson

European Journal of Health Economics, 2018, 19: 871-880.

A Comparison of Cost-Benefit and Cost-Effectiveness Analysis in Practice: Divergent Policy Practices in Sweden

Lars Hultkrantz and Mikael Svensson

Nordic Journal of Health Economics, 2017, 5: 41-53.

Valuation of small and multiple health risks: A critical analysis of SP data applied to food and water safety

Henrik Andersson, Arne Risa Hole and Mikael Svensson

Journal of Environmental Economics and Management, 2016, 75: 41-53.

The Willingness to Pay for a QALY: A Review of the Empirical Literature

Linda Ryen and Mikael Svensson

Health Economics, 2015, 24: 1289-1301.

Scale Sensitivity and Question Order in the Contingent Valuation Method

Henrik Andersson and Mikael Svensson

Journal of Environmental Planning and Management, 2014, 57: 1746-1761.

The Value of a Statistical Life in Sweden: A review of the empirical literature

Lars Hultkrantz and Mikael Svensson

Health Policy, 2012, 108: 302-310.

Willingness to Pay for Private and Public Safety: Why the Difference?

Mikael Svensson and Maria Vredin-Johansson

Accident Analysis & Prevention, 2010, 42: 1205-1212.

The Impact of Real Options on Willingness to Pay for Mortality Risk Reductions

Niclas Krüger and Mikael Svensson

Journal of Health Economics, 2009, 28: 563-569.

Cognitive Ability and Scale Bias in the Contingent Valuation Method: An Analysis of Willingness to Pay to Reduce Mortality Risks

Henrik Andersson and Mikael Svensson

Environmental and Resource Economics, 2008, 39: 481-495.

Applied Cost-Effectiveness Analyses: Patient-level data (trial-based & observational)

GuREx-MIH: cost-effectiveness analysis of extraction versus restorative treatment for first permanent molars affected by Molar-Incisor Hypomineralisation in 11-year-old Swedish children

Adnan Hajdarević, Emina Čirgić, Birgitta Jälevik, Agneta Robertson, Tobias Fagrell, Mikael Svensson and Nina Sabel

BMC Oral Health, 2026, 26: 126.

Gothenburg Breast Reconstruction (GoBreast) II protocol: A Swedish partially randomised patient preference, superiority trial comparing autologous and implant-based breast reconstruction

Emma Hansson, Jonas Löfstrand, Camilla Larsson, Alexandra Uusimaki, Karolina Svensson, Anna Ekman, Mikael Svensson and Anna Paganini

BMJ Open, 2024, 14: e084025.

Healthcare costs and survival in patients with non-functioning pituitary adenoma

Daniel Olsson, Mikael Svensson, Frida Labori, Anna De Geer and Gudmundur Johannsson

European Journal of Endocrinology, 2023, 188: 477-484.

Cost-Effectiveness of Exercise Therapy in Patients with Intermittent Claudication - A Comparison of Supervised Exercise, Home-Based Structured Exercise, and Walk Advice from the SUNFIT Trial

Hildigunnur Ulfsdottir, Maria Bäck, Asa Cider, Lennart Jivegård, Anna Sandberg, Joakim Nordanstig and Mikael Svensson

Journal of Clinical Medicine, 2023, 12: 5277.

Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia

Gracie Hsin-Min Wang, Mikael Svensson, Hui Shao, Scott Vuori, Haesuk Park

Journal of Managed Care & Specialty Pharmacy, 2023, 29: 884-895.

Physiotherapist or physician as primary assessor for patients with suspected knee osteoarthritis in primary care – a cost-effectiveness analysis of a pragmatic trial

Chan-Mei Ho-Henriksson, Mikael Svensson, Carina Thorstensson and Lena Nordeman

BMC Musculoskeletal Disorders, 2022, 23: 260.

Cost-Benefit Evaluation of an Organizational-level Intervention Program for Decreasing Sickness Absence Among Public Sector Employees in Sweden

Jonathan Severin, Mikael Svensson and Magnus Åkerström

International Journal of Environmental Research and Public Health: Occupational Safety and Health, 2022, 19, 2998.

Cost-effectiveness of endovascular intervention versus bypass surgery in patients with chronic limb-threatening ischemia and principal target lesion in the femoropopliteal segment

Angelica Perlander, Joakim Nordanstig, Klas Österberg and Mikael Svensson

Journal of Critical Limb Ischemia, 2022, 2, E19-E26.

Induction of labour at 41 weeks of gestation versus expectant management and induction of labour at 42 weeks of gestation: a cost-effectiveness analysis

Mårten Alkmark, Ulla-Britt Wennerholm, Sissel Saltvedt, Christina Bergh, Ylva Carlsson, Helen Elden, Helena Fadl, Maria Jonsson, Lars Ladfords, Verena Sengpiel, Jan Wesström, Henrik Hagberg and Mikael Svensson

BJOG: An International Journal of Obstetrics and Gynaecology, 2022, 129: 2157-2165.

The cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: 12-month economic evaluation of a pragmatic randomized controlled study

Anna Holst, Frida Labori, Cecilia Björkelund, Dominique Hange, Irene Svenningsson, Eva-Lisa Petersson, Jeanette Westman, Camilla Udo, Christina Möller and Mikael Svensson

Cost Effectiveness and Resource Allocation, 2021, 19:52.

The Economic Cost and Patient-Reported Outcome of Chronic Achilles Tendon Ruptures

Niklas Nilsson, Mikael Svensson, Katarina Nilsson Helander, Eric Hamrin Senorski, Anna Holm, Jón Karlsson and Olof Westin

Journal of Experimental Orthopaedics, 2020, 7: 60.

Absence of Long-Term Benefit of Revascularization in Patients With Intermittent Claudication

Henrik Djerf, Johan Millinger, Mårten Falkenberg, Lennart Jivegård, Mikael Svensson and Joakim Nordanstig

Circulation: Cardiovascular Interventions, 2020, 13: e008450.

Cost-effectiveness of revascularization in patients with intermittent claudication

Henrik Djerf, Mårten Falkenberg, Lennart Jivegård, Hans Lindgren, Mikael Svensson and Joakim Nordanstig

British Journal of Surgery, 2018, 105: 1742-1748.

Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: economic evaluation of a pragmatic randomised controlled study

Anna Holst, Annika Ginter, Cecilia Björkelund, Dominique Hange, Eva-Lisa Petersson, Irene Svenningsson, Jeanette Westman, Malin André, Carl Wikberg, Lars Wallin, Christina Möller and Mikael Svensson

BMJ Open, 2018, 8:e024741.

More cost-effective management of patients with musculoskeletal disorders in primary care after direct triaging to physiotherapists for initial assessment compared to initial general practitioner

Lena Bornhöft, Jörgen Thorn, Mikael Svensson, Lena Nordeman, Robert Eggertsen and Maria Larsson

BMC Musculoskeletal Disorders, 2019, 20: 186.

Cost-Effectiveness Analysis of Surgical vs. Non-surgical Management of Acute Achilles Tendon Ruptures

Olof Westin, Mikael Svensson, Katarina Nilsson-Helander, Kristian Samuelsson, Karin Grävare Silbernagel, Nicklas Olsson, Jón Karlsson and Elisabeth Hansson-Olofsson

Knee Surgery, Sports Traumatology, Arthroscopy, 2018, 26: 3074-3082.

A cost-effectiveness analysis of internet mediated cognitive behavioural therapy for depression in the primary care setting: results based on a controlled trial

Anna Holst, Cecilia Björkelund, Alexandra Metsini, Jens Henrik Madsen, Dominique Hange, Eva-Lisa Petersson, Maria Eriksson, Marie Kivi, Per-Åke Andersson and Mikael Svensson

BMJ Open, 2018, 8:e019716.

Applied Cost-Effectiveness Analyses: Decision models

Optimizing Age-Based Targeting in Ice Cleat Distribution Programs for Preventing Winter Fall Injuries: A Cost-Effectiveness Modeling Study”,

Carl Bonander, Johanna Gustavsson, Ulf Strömberg and Mikael Svensson

Injury Epidemiology, 2025, 13: 76.

Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People with Diabetes

Shu Niu, Dawei Guan, Lizheng Shi, Vivian Fonseca, Mikael Svensson, Mohammed Ali, Yan Sun, Xin Hu, Chang Su, Carl Yang and Hui Shao

Value in Health, 2025, 28: 762-768.

Cost-effectiveness analysis of monthly, 3-monthly, and 6-monthly long-acting injectable and oral paliperidone in adults with schizophrenia

Gracie Hsin-Min Wang, Mikael Svensson, Hui Shao, Scott Vuori and Haesuk Park

Journal of Managed Care & Specialty Pharmacy, 2023, 29: 884-895.

Cost-effectiveness of increased contraceptive coverage using family planning benefits cards

Elly Nuwamanya, Joseph Babigumira, and Mikael Svensson

Contraception and Reproductive Medicine, 2023, 8:21.

Cost-effectiveness analysis of temocillin treatment in febrile UTI patients

Sofie Larsson, Charlotta Edlund, Pontus Nauclér, Mikael Svensson and Anders Ternhag

Applied Health Economics and Health Policy, 2022, 20: 835-843.

Cost-effectiveness of cervical length screening and progesterone treatment to prevent spontaneous preterm delivery in Sweden

Tove Wikström, Pihla Kuusela, Bo Jacobsson, Henrik Hagberg, Peter Lindgren, Mikael Svensson, Ulla-Britt Wennerholm and Lil Valentin

Ultrasound in Obstetrics & Gynecology, 2022, 59, 778-792.

Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation

Frida Labori, Josefine Persson, Carl Bonander, Katarina Jood and Mikael Svensson

European Heart Journal, 2022, 43: 1348-1356.

A model-based economic evaluation of ice cleat distribution programs for the prevention of outdoor falls among adults from a Swedish societal perspective

Carl Bonander, Robin Holmberg, Johanna Gustavsson and Mikael Svensson

Injury Prevention, 2021, 28: 125-130.

The cost-effectiveness of a two-step blood pressure screening programme in a dental health-care setting

Helen Andersson, Mikael Svensson and Håkan Bergh

PLOS One, 2021, 16: e0252037.

Cost-Effectiveness of a universal pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation

Tayue Tateke Kebede, Mikael Svensson, Adamu Addissie, Birger Trollfors and Rune Andersson

BMC Public Health, 2019, 19: 1078.

Congenital Heart Defect Repair with ADAPT tissue engineered pericardium scaffold: An Early Stage Health Economic Model

Vladicka Velickovic, Oleg Borisenko, Mikael Svensson, Tim Spelman and Uwe Siebert

Plos One, 2018, 13:e0204643.

The Cost-Effectiveness of the Kiva Antibullying Program: Results from a Decision-Analytic Model

Mattias Persson, Linn Wennberg, Linda Beckman, Christina Salmivalli and Mikael Svensson

Prevention Science, 2018, 19: 728-737.

A cost-effectiveness analysis of lowering residential radon levels in Sweden - results from a modeling study

Mikael Svensson, Lars Barregård, Gösta Axelsson and Eva Andersson

Health Policy, 2018, 122: 687-692.

Modeling the Cost-Effectiveness of Impact-Absorbing Flooring in Swedish Residential Care Facilities

Linda Ryen and Mikael Svensson

European Journal of Public Health, 2016, 26: 407-4011.

The Cost-Effectiveness of the Olweus Bullying Prevention Program: Results from a Modelling Study

Linda Beckman and Mikael Svensson

Journal of Adolescence, 2016, 45: 127-137.

Health Technology Assessment & Clinical Effectiveness

GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias

Huilin Tang, William Donahoo, Steven DeKosky, Yao An Lee, Pareeta Kotecha, Mikael Svensson, Jian Biao, Jingchuan Guo

JAMA Neurology, 2025, 82: 439-449.

Heterogeneous Treatment Effects of GLP-1RAs and SGLT2is on Risk of Alzheimer's Disease and Related Dementia in Patients with Type 2 Diabetes: Insights from a Real-World Target Trial Emulation

Huilin Tang, William Donahoo, Steven DeKosky, Yao An Lee, Pareeta Kotecha, Mikael Svensson, Jiang Bian, Jingchuan Guo

Alzheimer's & Dementia, 2025, 21: e70313.

Glycated Hemoglobin and Body Mass Index as Mediators of GLP-1RAs and Alzheimer's Disease and Related Dementias in Patients with Type 2 Diabetes

Huilin Tang, William Donahoo, Steven DeKosky, Yao An Lee, Mikael Svensson, Jiang Bian, Jingchuan Guo

Alzheimer's & Dementia, 2025, 21: e70161.

A Systematic Review of Cost-Effectiveness Analyses of Gene Therapy for Hemophilia Type A and B

Alaa Alshehri, John Dougherty, Linda Beckman and Mikael Svensson

Journal of Managed Care and Specialty Pharmacy, 2024, 30: 1178-1188.

Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study

Hulin Tang, William Donahoo, Mikael Svensson, C. Elizabeth Shaaban, Glenn Smith, Michael Jaffee, Yu Huang, Xia Hu, Ying Lu, Ramzi Salloum, Steven DeKosky, Jing Bian, Jingchuan Guo

Alzheimer's & Dementia, 2024, 20: 5528-5539.

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-based Cohort Study

Huilin Tang, Ying Lu, Michael Okun, William Donahoo, Adolfo Ramirez-Zamora, F Wang, Yu Huang, Melissa Armstrong, Mikael Svensson, Beth Virnig, Steven DeKosky, Jian Bian, Jingchuan Guo

Movement Disorders, 2024, 39: 1960-1970.

Analyses of Quality of Life in Cancer Drug Trials - A Review of Measurements and Analytical Choices in Post-Reimbursement Studies

Mikael Svensson, Gabriella Chauca Strand, Carl Bonander, Naimi Johansson and Niklas Jakobsson

BMC Cancer, 2024, 24: 311.

A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies

Sumaya Abuloa, Shi Niu, Darlene Adirika, Benjamin P. Harvey and Mikael Svensson

Human Gene Therapy, 2024, 35: 365-373.

Systematic review of cost-effectiveness in breast reconstruction: deep inferior epigastric perforator flap (DEP) vs implant-based breast reconstruction

Emma Hansson, Fredrik Brorson, Jonas Löfstrand, Anna Elander and Mikael Svensson

Journal of Plastic Surgery and Hand Surgery, 2023, 59: 19649.

Disease-specific health-related quality of life in patients with chronic limb-threatening ischemia undergoing revascularization of femoropopliteal lesions

Angelica Perlander, Monica Broeren, Klas Osterberg, Mikael Svensson and Joakim Nordanstig

European Journal of Vascular & Endovascular Surgery, 66: 245-251.

Progesterone, cerclage, pessary, or acetylsalicylic acid for prevention of preterm birth in singleton and multifetal pregnancies - a systematic review and meta-analyses

Ulla-Britt Wennerholm, Lina Bergman, Pihla Kuusela, Elin Ljungström, Anna Möller, Cecilia Hongslo Vala, Ann-Catrin Ekelund, Ann Liljegren, Max Petzold, Petteri Sjögren, Mikael Svensson, Annika Strandell, and Bo Jacobsson

Frontiers in Medicine: Obstetrics and Gynecology, 2023, Vol 10.

Safety, effectiveness, women's experience, and economic costs of outpatient induction in women with uncomplicated pregnancies: a systematic review and meta-analyses

Heléne Sangskär, Lisa Berglin, Verena Sengpiel, Therese Svanberg, Mikael Svensson, Beatrice Berter, Helen Elden, Petteri Sjögren, Annika Strandell and Ylva Carlsson

International Journal of Gynecology & Obstetrics, 2023, 161: 343-355.

Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment – a systematic review and meta-analysis

Frida Labori, Carl Bonander, Josefine Persson and Mikael Svensson

Journal of Interventional Cardiac Electrophysiology, 2021, 61: 215-225.

A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research

Emmeli Widmark-Jensen, Susanne Bernhardsson, Maud Eriksson, Håkan Hallberg, Christian Jepsen, Lennart Jivegård, Ann Liljegren, Max Petzold, Mikael Svensson, Fredrik Wärnberg and Emma Hansson

BMC Surgery, 2021, 21: 343.

Results of renal artery revascularization in the post-ASTRAL era with 4 years mean follow-up

Karin Zachrisson, Ferid Krupic, Mikael Svensson, Ann Wigelius, Andreas Jonsson, Angeliki Dimopoulou, Anna Stenborg, Gert Jensen, Hans Herlitz, Anders Gottsäter and Mårten Falkenberg

Blood Pressure, 2020, 29: 285-290.

Electroencephalography-based neurofeedback as treatment for post-traumatic stress disorder: a systematic review and meta-analysis

Steinn Steingrimsson, Gorana Bilonic, Ann-Catrin Ekelund, Tomas Larson, Ida Stadig, Mikael Svensson, Iris Sarajilic Vukovic, Constanze Wartenberg, Nils Olov Wrede and Susanne Bernhardsson

European Psychiatry, 2020, 63: E7.

Amputation-free survival, limb symptom alleviation, and reintervention rates after open and end-vascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia

Angelica Perlander, Lennart Jivegård, Joakim Nordanstig, Mikael Svensson and Klas Österberg

Journal of Vascular Surgery, 2020, 72: 1987-1995.

Long-term outcome of stenting for atherosclerotic renal artery stenosis and the effect of angiographic restenosis

Karin Zachrisson, Sven Elverfors, Gert Jensen, Mikael Hellström, Mikael Svensson, Hans Herlitz and Mårten Falkenberg

Acta Radiologica, 2018, 59: 1438-1445.

Part-time sick leave as a treatment method for individuals with muskuloskeletal disorders

Daniela Andrén and Mikael Svensson

Journal of Occupational Rehabilitation, 2012, 22: 418-426.

Cost of Illness & Consequences

The impact of multimorbidity among adults with cardiovascular diseases on healthcare costs in Indonesia: a multilevel analysis

Royasia Viki Ramadini, Mikael Svensson, Sven Hassler, Budi Hidayat and Nawi Ng

BMC Public Health, 2024, 24:816.

The impact of stroke on spousal and family income: a difference-in-difference study from Swedish national registries

Frida Labori, Josefine Persson, Mikael Svensson and Carl Bonander

Topics in Stroke Rehabilitation, 2023, 31: 381-389.

Lifetime healthcare expenditures across socioeconomic groups in Sweden

Stephanie Fledsberg, Mikael Svensson and Naimi Johansson

European Journal of Public Health, 2023, 33: 994-1000.

The economic cost of COVID-19 - Iceland, Norway, and Sweden

Lars Hultkrantz and Mikael Svensson

Nordic Economic Policy Review, 2022, 114-136.

Production loss and sick leave caused by antibiotic resistance: a register-based cohort study

Sofie Larsson, Mikael Svensson and Anders Ternhag

BMC Public Health, 2022, 22: 527.

A health economic assessment of air pollution effects under climate neutral vehicle fleet scenarios in Stockholm, Sweden

Hedi Kriit, Bertil Forsberg, Stefan Åström, Johan Sommar, Mikael Svensson and Christer Johansson

Journal of Transport & Health, 2021, 22: 101084.

Economic Costs of Antidepressant Use: A Population Based Study in Sweden

Linda Beckman, Laura von Kobyletzki and Mikael Svensson

The Journal of Mental Health Policy and Economics, 2019, 22: 125-130.

Long-term cost of spouses' informal support for dependent midlife stroke survivors

Josefine Persson, Lars-Åke Levin, Lukas Holmegaard, Petra Redfors, Mikael Svensson, Katarina Jood, Christina Jern, Christian Blomstrand and Gunilla Forsberg-Wärleby

Brain and Behavior, 2017, 7: e000716.

Catastrophic health expenditure and impoverishment in Mongolia

Dorjdagva Javkhlanbayr, Batbaatar Enkhjargal, Svensson Mikael, Dorjsuren Bayarsaikhan, Kauhanen Jussi

International Journal for Equity in Health, 2016, 15: 105.

The economic cost of brain disorders in Europe

Olesen Jes, Gustavsson Anders, Svensson Mikael, Wittchen H-U and Jönsson Bengt

European Journal of Neurology, 2012, 19: 155-162.

Cost of disorders of the brain in Europe 2010

Gustavsson Anders, Svensson Mikael, Jacobi Frank, Allgulander Christer, Alosno Jordi, Beghi Ettore et al.

European Neuropsychopharmacology, 2011, 21: 718-779.

Public Health

A quasi-experimental evaluation of municipal ice cleat distribution programmes for older adults in Sweden

Elin Eklund, Robin Holmberg, Mikael Svensson, Johanna Gustavsson and Carl Bonander

Injury Prevention, 2023, 29: 378-383.

Ice cleat distribution programs and ice cleat use among older adults: repeated cross-sectional evidence from 63 municipal interventions in Sweden

Robin Holmberg, Johanna Gustavsson, Mikael Svensson and Carl Bonander

Injury Prevention, 2022, 28: 539-544.

Does social health insurance prevent financial hardship in Mongolia? Inpatient care: A case in point

Javkhlanbayar Dorjdagva, Enkhjargal Batbaatar, Mikael Svensson, Bayarsaikhan Dorjsuren, Munkhsaikhan Togtmol and Jussi Kauhanen

PLOS One, 2021, 16(3): e0248518.

From Loss of Life to Loss of Years: A Different View on the Burden of Injury Fatalities in Sweden 1972-2014

Linda Ryen, Carl Bonander and Mikael Svensson

European Journal of Public Health, 2018, 28: 853-858.

Classmate characteristic's, class composition and children's perceived classroom climate

Louise Persson and Mikael Svensson

Journal of Public Health, 2017, 25: 473-480.

Effects on Alcohol Use of a Swedish School-Based Prevention Program for Early Adolescents: A Longitudinal Study

Linda Beckman, Mikael Svensson, Susanna Geidne and Charli Eriksson

BMC Public Health, 2017, 17:2.

Do Knowledge Gains from Public Information Campaigns Persist Over Time? Results from a Survey Experiment on the Norwegian Pension Reform

Henning Finseraas, Niklas Jakobsson and Mikael Svensson

Journal of Pension Economics and Finance, 2017, 16: 108-117.

Demographic determinants of incidence experience and risk perception: Do high-risk Groups accurately perceive themselves as high-risk?

Björn Sund, Mikael Svensson and Henrik Andersson

Journal of Risk Research, 2017, 20: 99-117.

Free and universal, but unequal utilization of primary health care in the rural and urban areas of Mongolia

Javkhlanbayar Dorjdagva, Enkhjargal Batbaatar, Mikael Svensson, Bayarsaikhan Dorjsuren, Burenjargal Batmunkh, and Jussi Kauhanen

International Journal for Equity in Health, 2017, 16:73.

Preference-Based Health-Related Quality of Life among Victims of Bullying

Linda Beckman, Mikael Svensson and Ann Frisén

Quality of Life Research, 2016, 25: 303-309.

The Willingness to Pay to Reduce School Bullying

Mattias Persson and Mikael Svensson

Economics of Education Review, 2013, 35: 1-11.

Class-Size Effects on Adolescents' Mental Health and Well-Being in Swedish Schools

Niklas Jakobsson, Mattias Persson and Mikael Svensson

Education Economics, 2013, 21: 248-263.

Mortality and economic fluctuations

Niclas Krüger and Mikael Svensson

Journal of Population Economics, 2012, 25: 1215-1235.

The size and burden of mental disorders and other disorders of the brain in Europe 2010

Wittchen H.U., Jacobi F., Rehm J., Gustavsson A., Svensson Mikael and Jönsson B. et al.

European Neuropsychopharmacology, 2011, 21: 655-679.

Adolescent Alcohol-use and Economic Conditions: findings from a multilevel study during a period of big economic changes

Mikael Svensson and Curt Hagquist

European Journal of Health Economics, 2010, 11: 533-541.

Adolescent Alcohol- and Illicit Drug-Use in First and Second Generation Immigrants in Sweden

Mikael Svensson and Curt Hagquist

Scandinavian Journal of Public Health, 2010, 38: 184-191.

Economic Upturns are Good for Your Heart but Watch out for Accidents

Mikael Svensson

Applied Economics, 2010, 42(5): 615-625.

Good Times are Drinking Times: Empirical Evidence on Business Cycles and Alcohol Sales in Sweden 1861-2000

Niclas Krüger and Mikael Svensson

Applied Economics Letters, 2010, 17: 543-546.

Don't Go Breaking your Heart: Do Economic Upturns Really Increase Heart Attack Mortality?

Mikael Svensson

Social Science & Medicine, 2007, 65: 833-841.

Other

Universities as engines for regional growth? Using the synthetic control method to analyze the effects of research universities

Carl Bonander, Niklas Jakobsson, Federico Podestá and Mikael Svensson

Regional Science and Urban Economics, 2016, 60: 198-207.